Pharmaceutical
Health
Therapy

Zogenix

$48.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (0.29%) Today
$0.00 (0.00%) As of 4:06 PM EDT after-hours

Why Robinhood?

You can buy or sell Zogenix and other stocks, options, ETFs, and crypto commission-free!

About ZGNX

Zogenix, Inc. Common Stock, also called Zogenix, is a pharmaceutical compan. Read More It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.

Employees
90
Headquarters
Emeryville, California
Founded
2006
Market Cap
2.04B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
346.65K
High Today
$48.44
Low Today
$47.75
Open Price
$47.89
Volume
294.97K
52 Week High
$59.85
52 Week Low
$33.43

Collections

Pharmaceutical
Health
Therapy
Technology

ZGNX News

BenzingaJun 27

Zogenix Secures FDA Approval For Resubmission Of Seizure Drug Application

1,193

ZGNX Earnings

-$1.17
-$0.96
-$0.74
-$0.53
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours

More ZGNX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.